Patrick Aisher

PreComb Therapeutics AG is a Swiss company that specializes in functional precision medicine for oncology and cancer. The company is based in Hombrechtikon, Switzerland. The company uses organoid and predictive technologies, as well as AI and data mining, to guide therapy and automate processes. The company also works in immune oncology and collaborate with other organizations such as 2curex, Xilis, USZ, DKFZ, and NCT. The company was founded in 2018 by Peter Steiner and Jens M. Kelm, with Jens M. Kelm serving as CEO since then.

PreComb Therapeutics AG is a Swiss company that specializes in functional precision medicine for oncology and cancer. The company is based in Hombrechtikon, Switzerland. The company uses organoid and predictive technologies, as well as AI and data mining, to guide therapy and automate processes. The company also works in immune oncology and collaborate with other organizations such as 2curex, Xilis, USZ, DKFZ, and NCT. The company was founded in 2018 by Peter Steiner and Jens M. Kelm, with Jens M. Kelm serving as CEO since then.

The Swiss Private Equity & Corporate Finance Association (SECA) is an organization that represents the private equity, venture capital, and corporate finance industries in Switzerland. The non-profit company is based in Switzerland. SECA aims to promote and support these activities within the country.

The Swiss Private Equity & Corporate Finance Association (SECA) is an organization that represents the private equity, venture capital, and corporate finance industries in Switzerland. The non-profit company is based in Switzerland. SECA aims to promote and support these activities within the country.

The Swiss Private Equity & Corporate Finance Association (SECA) is an organization that represents the private equity, venture capital, and corporate finance industries in Switzerland. The non-profit company is based in Switzerland. SECA aims to promote and support these activities within the country.